insights_auto
Why is NEO down 3,58%?
Dive Deeperchevron_right
NEO:NASDAQ
NeoGenomics, Inc.
18,60 $
arrow_downward
-3,58%(-0,69) 1D
29 սեպ, 12:16:58 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
19,30 $
High
19,75 $
Low
18,58 $
Mkt. cap
2,39 մլրդ
Avg. vol.
1,91 մլն
Volume
977,70 հզր
52-wk high
20,05 $
52-wk low
7,06 $
EPS
-0,40 $
Beta
1,75
Shares outstanding
128,48 մլն
No. of employees
2 հզր
Open
19,30 $
High
19,75 $
Low
18,58 $
Mkt. cap
2,39 մլրդ
Avg. vol.
1,91 մլն
Volume
977,70 հզր
52-wk high
20,05 $
52-wk low
7,06 $
EPS
-0,40 $
Beta
1,75
Shares outstanding
128,48 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
AD HOC NEWS
·
3 ժամ առաջ
NeoGenomics stock trades at EUR 17.04 after Q2 EPS beat
https://www.dars.gov.et/
·
1 ամիս առաջ
NeoGenomics Shares Hit Two-Year High After Landmark First Profit - Return On Capital
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2,5 հզր
Founded2002
HeadquartersՖորտ Մայերս, Ֆլորիդա, Միացյալ Նահանգներ
SectorHealth care provider
Websiteneogenomics.com